Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Otsuka Scores Twice in One Week

Otsuka Scores Twice in One Week

Otsuka Pharmaceutical Co., Ltd., a subsidiary of Otsuka Holdings (OTC: OTSKY), announced back-to-back deals in early July, in which it entered a new field, and bolstered one of its existing segments. Otsuka’s research areas are in psychiatric and neurological diseases, hematological cancers, and kidney, cardiovascular, and infectious diseases. On July 11, the company announced its acquisition of ReCor Medical, a portfolio company of Sofinnova Partners, for an undisclosed price. The Palo Alto, California-based medical device company specializes in the treatment of hypertension, a new area for Otsuka. ReCor was founded in 2009 by Sofinnova Partners and Professor Jacques Seguin, MD, who... Read More »
Health Care M&A Weekly Deals, Week Ending July 6, 2018

Health Care M&A Weekly Deals, Week Ending July 6, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Hospitals Acquirer Target Price ApolloMed Holdings and AMHC Healthcare The French Hospital $33 million Long-Term Care Acquirer Target Price Griffin-American Healthcare REIT IV Pelican Bay Assisted Living & Memory Care $19.5 million... Read More »
Q2:18 Health Care Deal Volume and Value Explode

Q2:18 Health Care Deal Volume and Value Explode

What a quarter it was. Even with preliminary data, the numbers of deals and dollars spent in the second quarter of 2018 are impressive. The quarter began with a bang in April (176 deals), settled in May (136 deals) and slowed in June (122 deals). That still adds up to 432 transactions reported in the second quarter, up 1% compared with the first quarter, and 13% better than the same quarter in 2017. The Services sectors accounted for 59% of the deal volume in Q1:18, five percentage points lower than in the previous quarter, and three percentage points lower than Q2:17. The Long-Term Care sector, which turned in 47 deals in April alone, posted gains of 28% compared with Q1:18 and 33%... Read More »
June 2018 Deal Volume Settles into Summer Mode

June 2018 Deal Volume Settles into Summer Mode

June was a gentle month for deal making. As the first month of summer, preliminary data shows a slight drop in deal volume for the month, compared with a busier May. Investors seem to be taking the adage “Buy in May and go away” seriously. With a preliminary total of 122 transactions made public in June 2018, deal volume was down 10% compared with May’s 135 deals. Deal volume compared to June 2017 was off 8%. Long-Term Care deals, which typically make up the greatest share of monthly volume, were down to just 22 transactions (18% share) compared with 35 in the previous month. That’s the way the second quarter played out in this sector, with April deal volume spiking... Read More »
Catalent Takes Juniper Pharmaceuticals Private

Catalent Takes Juniper Pharmaceuticals Private

Catalent, Inc. (NASDAQ: CTLT), a contract research organization (CRO), announced its acquisition of thinly traded nano cap Juniper Pharmaceuticals (NASDAQ: JPR) for $139.6 million. Catalent, based in Somerset, New Jersey, offers development services, delivery technologies and supply solutions for drugs and biologics. On a trailing 12-month basis, the company generated revenue of $2.4 billion, and EBITDA of $484.6 million. Juniper, based in Boston, Massachusetts, focuses on developing novel intra-vaginal therapeutics that address unmet medical needs in women’s health. This deal includes Juniper’s UK-based Juniper Pharma Services division, a high-end CRO. The transaction... Read More »
Boston Scientific Announces Fourth Deal in 2018

Boston Scientific Announces Fourth Deal in 2018

In a quiet holiday week, Boston Scientific Corporation (NYSE: BSX) made some news with its $202 million acquisition of privately held Criterion Medical, Inc. Founded in 2016, Criterion Medical has developed a single-shot cryoablation platform for the treatment of atrial fibrillation (AF). Boston Scientific already held a 35% stake in the Carlsbad, California-based company. The $202 million paid for the 65% it didn’t already own. The addition of this cryoballoon platform positions Boston Scientific as the first to have both cryothermal and radiofrequency (RF) single-shot, balloon-based ablation therapies in its portfolio. This is Boston Scientific’s fourth announced acquisition... Read More »
Health Care M&A Weekly Deals, Week Ending July 6, 2018

Health Care M&A Weekly Deals, The Week Ending June 29, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price BelHealth Investment Partners Beach House Center for Recovery N/A Biotechnology Acquirer Target Price Akebia Therapeutics, Inc. Keryx Biopharmaceuticals, Inc. Merger Bio-Techne Corporation... Read More »
Amazon Scoops Up PillPack for $1 Billion

Amazon Scoops Up PillPack for $1 Billion

Amazon (NASDAQ: AMZN) finally took the plunge into the pharmaceutical market with its approximately $1 billion acquisition of five-year-old PillPack, an online pharmacy startup based in Manchester, New Hampshire. Financial terms weren’t disclosed in the deal’s announcement, but on June 28, the day of the announcement, The Wall Street Journal quoted sources on the price. In April 2018, Walmart (NYSE: WMT) was reported to be in discussions with PillPack, and targeting a price under $1 billion, according to CNBC. Amazon was also said to be holding  discussions with the company at the time. PillPack is an online pharmacy that delivers medications in pre-sorted dose packaging and... Read More »
Lourdes Health Merges with Virtua

Lourdes Health Merges with Virtua

In early June, the boards of Virtua Health and Maxis Health System, an entity of Trinity Health, signed a definitive agreement to merge Maxis Health’s Lourdes Health System with Virtua. Virtua Health operates three hospitals in South Jersey, as well as the 500-physician Virtua Medical Group, eight urgent care centers, multiple ambulatory surgery centers, home health services, long-term care and rehabilitation centers. Lourdes Health System, based in Camden, New Jersey, is one of the region’s leading healthcare providers. It consists of two hospitals, Our Lady of Lourdes Medical Center (257 beds) in Camden, Lourdes Medical Center of Burlington County (122 beds), Lourdes Medical... Read More »
MedEquities Realty Acquires Vibra IRF Assets

MedEquities Realty Acquires Vibra IRF Assets

Vibra Healthcare LLC has sold the real estate assets of its 60-bed Southern Indiana Rehabilitation Hospital, an inpatient rehabilitiation facility (IRF) it acquired on April 30 this year from KentuckyOne, a subsidiary of Ascension. The hospital is located in New Albany, Indiana, a suburb of Louisville, Kentucky, where KentuckyOne is based. The buyer, MedEquities Realty Trust, Inc. (NYSE: MRT), agreed to pay $23.4 million for the 64,380-square foot facility, with an average price-per-bed of $390,000. The company concurrently executed a 15-year triple-net lease of the IRF with Vibra at an initial lease rate of 9.0% with annual escalators. Vibra will convert the 26 beds currently used as... Read More »